Skip to main content
. 2022 Oct 17;11(20):e026236. doi: 10.1161/JAHA.122.026236

Table 5.

Operative Outcomes After Mitral Valve Surgery

Operative outcomes Mitral surgery
Operative mortality, n (%) 2 (4.5)
Length of mechanical ventilation, h (IQR) 9.2 (4.0–51.0)
Intensive care unit length of stay, h (IQR) 66.0 (24.0–139.7)
Hospital length of stay, d (IQR) 10.6 (7.0–22.5)
Postoperative atrial fibrillation, n (%) 15 (34.1)
Pneumonia, n (%) 9 (20.4)
Renal failure, n (%) 10 (22.7)
Delayed sternal closure, n (%) 5 (11.3)
Gastrointestinal bleeding, n (%) 4 (13.6)
Intra‐aortic balloon pump use, n (%) 4 (9.1)
Sepsis, n (%) 2 (4.5)
Extracorporeal membrane oxygenation use, n (%) 2 (4.5)
Reexploration for surgical bleeding, n (%) 1 (0.3)
Stroke, n (%) 1 (0.3)

IQR indicates interquartile range.